Bukwang Pharmaceutical Co., Ltd. (KRX: 003000)

Bukwang Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 11, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	344,327	417,573	598,978	883,065	1,924,170	918,379
Market Cap Growth	-25.66%	-30.29%	-32.17%	-54.11%	109.52%	-41.71%
Enterprise Value	319,347	368,683	519,044	826,852	1,868,498	866,812
Last Close Price	5030.00	6100.00	8750.00	12758.86	27582.81	12761.19
PE Ratio	-	-13.32	-242.03	-952.93	-262.69	-123.13
PS Ratio	2.96	3.32	3.14	4.84	11.34	5.46
PB Ratio	1.53	1.78	2.20	3.15	7.10	2.81
P/FCF Ratio	17.00	-34.24	49.24	34.31	-1611.40	-34.08
P/OCF Ratio	16.78	-44.60	36.39	33.29	2660.75	-39.23
EV/Sales Ratio	2.74	2.93	2.72	4.53	11.01	5.15
EV/EBITDA Ratio	-9.24	-11.10	106.23	79.01	183.44	56.37
EV/EBIT Ratio	-8.17	-9.83	-2250.49	147.08	463.86	90.89
EV/FCF Ratio	15.77	-30.23	42.67	32.12	-1564.77	-32.17
Debt / Equity Ratio	0.35	0.34	0.00	0.01	0.08	0.01
Debt / EBITDA Ratio	-	-	0.19	0.15	2.12	0.14
Debt / FCF Ratio	3.93	-6.51	0.08	0.06	-18.04	-0.08
Asset Turnover	0.32	0.30	0.48	0.46	0.43	0.38
Inventory Turnover	1.47	1.66	2.87	2.36	2.06	2.17
Quick Ratio	4.51	1.93	3.90	4.79	3.16	3.92
Current Ratio	6.50	2.61	4.90	5.95	4.06	5.19
Return on Equity (ROE)	-13.68%	-13.60%	-1.54%	-1.01%	-3.38%	-2.01%
Return on Assets (ROA)	-6.02%	-5.65%	-0.04%	0.88%	0.64%	1.35%
Return on Capital (ROIC)	-7.67%	-7.99%	-0.05%	1.22%	0.81%	1.61%
Earnings Yield	-9.14%	-7.50%	-0.41%	-0.10%	-0.37%	-0.81%
FCF Yield	5.88%	-2.92%	2.03%	2.91%	-0.06%	-2.93%
Buyback Yield / Dilution	-0.72%	-	0.01%	0.25%	4.24%	1.37%
Total Shareholder Return	-0.72%	-	0.01%	0.25%	4.24%	1.37%

Source: S&P Capital IQ. Standard template. Financial Sources.